Indirect evidence for nitric oxide involvement in multiple sclerosis by characterization of circulating antibodies directed against conjugated S-nitrosocysteine

J Neuroimmunol. 1995 Jul;60(1-2):117-24. doi: 10.1016/0165-5728(95)00061-6.

Abstract

Converging data suggest that nitric oxide (NO) production by cytokine-induced immune cells in demyelinating lesions is involved in multiple sclerosis (MS). High levels of NO may complex to suitable amino acids, causing an immune response against the formed neo-epitopes. By testing MS sera with chemically defined nitroso-amino acids conjugated to carrier protein in ELISA, we observed a significant antibody reaction against the S-nitroso-cysteine epitope. The MS antibody response was exclusively of IgM isotype with an avidity of 8 x 10(-7) M. Sera of all clinical MS forms showed a significantly elevated antibody titer versus sera from healthy subjects or from patients affected with other neurological and autoimmune diseases. The detection of circulating antibodies to a conjugated S-nitroso-cysteine epitope provides indirect evidence for NO involvement in MS.

Publication types

  • Comparative Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Antibodies / immunology*
  • Autoimmune Diseases / immunology
  • Cysteine / analogs & derivatives*
  • Cysteine / immunology
  • Epitopes
  • Female
  • Humans
  • Immunoglobulin M / immunology
  • Male
  • Middle Aged
  • Multiple Sclerosis / immunology*
  • Nervous System Diseases / immunology
  • Nitric Oxide / immunology*
  • Reference Values
  • S-Nitrosothiols*

Substances

  • Antibodies
  • Epitopes
  • Immunoglobulin M
  • S-Nitrosothiols
  • Nitric Oxide
  • S-nitrosocysteine
  • Cysteine